Literature DB >> 23913144

Pharmacokinetics and ADME characterizations of antibody-drug conjugates.

Kedan Lin1, Jay Tibbitts, Ben-Quan Shen.   

Abstract

Pharmacokinetic and absorption, distribution, metabolism, and excretion (ADME) characterization of antibody-drug conjugates (ADCs) reflects the dynamic interactions between the biological system and ADC, and provides critical assessments in lead selection, optimization, and clinical development. Understanding the pharmacokinetics (PK), ADME properties and consequently the pharmacokinetic-pharmacodynamic properties of ADCs is critical for their successful development. This chapter discusses the PK properties of ADCs, types of PK and ADME studies in supporting different stages of development, general design of PK/ADME studies with a focus on ADC-specific characteristics, and interpretation of PK parameters.

Mesh:

Substances:

Year:  2013        PMID: 23913144     DOI: 10.1007/978-1-62703-541-5_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  Antibody-Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons Learned.

Authors:  William D Hedrich; Tamer E Fandy; Hossam M Ashour; Hongbing Wang; Hazem E Hassan
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

2.  Development and Translational Application of an Integrated, Mechanistic Model of Antibody-Drug Conjugate Pharmacokinetics.

Authors:  Siddharth Sukumaran; Crystal Zhang; Douglas D Leipold; Ola M Saad; Keyang Xu; Kapil Gadkar; Divya Samineni; Bei Wang; Marija Milojic-Blair; Montserrat Carrasco-Triguero; Bonnee Rubinfeld; Paul Fielder; Kedan Lin; Saroja Ramanujan
Journal:  AAPS J       Date:  2016-09-27       Impact factor: 4.009

3.  Aberrant intracellular metabolism of T-DM1 confers T-DM1 resistance in human epidermal growth factor receptor 2-positive gastric cancer cells.

Authors:  Hongbin Wang; Wenqian Wang; Yongping Xu; Yong Yang; Xiaoyan Chen; Haitian Quan; Liguang Lou
Journal:  Cancer Sci       Date:  2017-05-23       Impact factor: 6.716

4.  High throughput screening against pantothenate synthetase identifies amide inhibitors against Mycobacterium tuberculosis and Staphylococcus aureus.

Authors:  Sayantan Pradhan; Chittaranjan Sinha
Journal:  In Silico Pharmacol       Date:  2018-05-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.